Kurt Sheline

Partner @ Echo Health Ventures

📍 Seattle, Washington, United States🔄 Updated September 2026💼 13 investments📅 9 years investing🗓 Last invested May 2026
VC🌍 United StatesInvested this year
13
Total investments
2
Early stage
5
Mid stage
3
Late stage
9y
Years active

Portfolio

11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
May 2026
InStride Health is an insurance-based, specialty provider delivering life-changing anxiety and OCD care for kids, teens, young adults (ages 7-24), and their families. Grounded in cognitive behavioral therapy (CBT), InStride’s evidence-based approach focuses on exposure therapy to help young people face their fears and anxieties in the places and situations that matter most. Our dedicated care team of a therapist, exposure coach, and psychiatrist, teaches youth and their families the skills needed to see lasting results.
Board Observer
May 2026
Optura is an AI orchestration company committed to transforming healthcare by unlocking the full potential of artificial intelligence. Guided by a team of proven experts from the healthcare and technology sectors, we specialize in delivering value-driven AI solutions that scale enterprise productivity and deliver rapid, measurable ROAI (Return On AI Investment) through our cutting-edge platform. Our mission is clear: to empower healthcare organizations to confidently embrace AI and help healthcare break free from its 17%+ pull on the GDP. At Optura, we’re not just enabling AI—we’re shaping a future where technology becomes a catalyst for meaningful healthcare transformation.
Board Observer
Jan 2024
Thyme Care is a value-based oncology management platform whose mission is to improve the quality of life for people diagnosed with cancer by providing personalized, clinically coordinated care. Thyme Care pairs human guidance with software and analytics to quickly connect members to the right care and provide ongoing support through targeted, evidence-based interventions. Founded by oncology industry veterans and clinicians, the companys approach prioritizes deep provider relationships and integrates with a health plan’s existing infrastructure, coordinating value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed with venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, Thyme Care partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.
Board Observer
Apr 2023
Cortica is a leading provider of ABA and other therapies for children with autism, with services available in-center, in-home, and via telehealth. Cortica’s personalized, whole-child approach integrates diagnostic services, medical services for autism’s co-occurring conditions, developmental therapies including occupational therapy and speech-language therapy, and individual and family counseling, all under one roof. For more information, please visit corticacare.com.
Board Observer
Sep 2022
Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology-enabled care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 121,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.
Board Observer
Mar 2021
Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don’t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Sciphers platform identifies which drug will work based on the patients fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
Board Observer
Dec 2020
Quartet is a technology-enabled care delivery company that delivers speed to quality behavioral healthcare for all. Quartet’s technology and services identify people who need care, connect them to high quality care through networks of providers or Quartet’s medical group, and support their care journeys. Quartet partners with health insurance plans, health systems, community behavioral health centers, certified community behavioral health clinics, and federally qualified health centers in 36 states across the country. Quartet is backed by top investors like Oak HC/FT, GV (formerly Google Ventures), F-Prime Capital Partners, Polaris Partners, Deerfield Management, Centene Corporation, Independence Health Group, and Echo Health Ventures.
Board Member
Nov 2019
Our mission is to help anyone concerned about their mental health or affected by addiction live amazing lives. We treat addiction like a chronic illness, and our evidence-based treatment model focuses on clinical and non-clinical factors, including medication, therapy, counseling, and meaningful connection to resources. We recognize that every Eleanor community member is a unique individual and treat them with dignity and compassion. Our commitment to their health and wellbeing is unwavering and without judgment. Because we are passionate about transforming the access, delivery and quality of addiction treatment, we are the first addiction and mental health service designed to deliver long-term recovery outcomes through value-based care. Our treatment approach meet patients where they are in their recovery journey, through outpatient clinics, community settings and at home through technology and field-based teams.
Board Observer
Mar 2018
Octave® Bioscience Inc. is a commercial stage precision-medicine company delivering a new paradigm of care for Multiple Sclerosis and other neurodegenerative diseases. Octave’s Precision Care Solution is the industry’s first set of measurement tools that accurately and objectively measure disease activity, progression, and severity, allowing for better management of complex and high-cost neurodegenerative diseases, starting with Multiple Sclerosis and expanding into Parkinson’s disease. The Octave Solution includes the Octave MSDA Test, the first and only multivariate blood test for Multiple Sclerosis, that measures disease activity, enhanced MRI analytics and protocols, and a clinical care program that tracks and connects patients with MS certified nurse care partners in real time. By combining and analyzing multiple biological and contextual layers of data, delivering longitudinal and holistic perspectives of each patient, and revealing insights at population levels, the Octave Solution addresses unmet needs across the entire ecosystem of care, from patients and providers to pharma and payers. Octave is currently collaborating with leading clinics, payers, and pharma companies across the country.
Board Observer
Jan 2018
Imagine a world where every healthcare and benefits program decision is backed and guided by data. Springbuk is the health data analytics solution that equips you with the insights and expertise you need to sharpen your benefits strategy, advance employee health, and contain costs. Unlike legacy data warehouses, we simplify data-driven decision-making with an intuitive user experience, predictive modeling, and curated action steps. Springbuk — a world of actionable health intelligence insight, at your fingertips. Visit springbuk.com to learn more.
Board Observer
Jul 2017
Circulation is the first customizable, patient-centric digital transportation platform that seamlessly integrates with both healthcare systems and health plans, and delivers a full suite of on-demand ride options including TNC, door-to-door, wheelchair and stretcher. Our founding team, staff, investors, and strategic partners represent expertise and leadership from organizations like: Humana, LabCorp, Intermountain Healthcare, Boston Children’s Hospital, athenahealth, Harvard Medical School, Flare Capital, and Echo Health Ventures. We are passionate about improving health outcomes and we're on a mission to fundamentally change the way individuals consume healthcare.
Experience · 17 entries
All (17)
Investments (13)
Board (13)
2026
Board Observer
May 2026
InStride Health is an insurance-based, specialty provider delivering life-changing anxiety and OCD care for kids, teens, young adults (ages 7-24), and their families. Grounded in cognitive behavioral therapy (CBT), InStride’s evidence-based approach focuses on exposure therapy to help young people face their fears and anxieties in the places and situations that matter most. Our dedicated care team of a therapist, exposure coach, and psychiatrist, teaches youth and their families the skills needed to see lasting results.
Board Observer
May 2026
Optura is an AI orchestration company committed to transforming healthcare by unlocking the full potential of artificial intelligence. Guided by a team of proven experts from the healthcare and technology sectors, we specialize in delivering value-driven AI solutions that scale enterprise productivity and deliver rapid, measurable ROAI (Return On AI Investment) through our cutting-edge platform. Our mission is clear: to empower healthcare organizations to confidently embrace AI and help healthcare break free from its 17%+ pull on the GDP. At Optura, we’re not just enabling AI—we’re shaping a future where technology becomes a catalyst for meaningful healthcare transformation.
2024
Board Observer
Jan 2024
Thyme Care is a value-based oncology management platform whose mission is to improve the quality of life for people diagnosed with cancer by providing personalized, clinically coordinated care. Thyme Care pairs human guidance with software and analytics to quickly connect members to the right care and provide ongoing support through targeted, evidence-based interventions. Founded by oncology industry veterans and clinicians, the companys approach prioritizes deep provider relationships and integrates with a health plan’s existing infrastructure, coordinating value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed with venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, Thyme Care partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.
2023
Board Observer
Apr 2023
Cortica is a leading provider of ABA and other therapies for children with autism, with services available in-center, in-home, and via telehealth. Cortica’s personalized, whole-child approach integrates diagnostic services, medical services for autism’s co-occurring conditions, developmental therapies including occupational therapy and speech-language therapy, and individual and family counseling, all under one roof. For more information, please visit corticacare.com.
2022
Board Observer
Sep 2022
Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology-enabled care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 121,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.
Show all 17 entries ↓
Investment activity
2017–2026 · 13 investments
201722018220192202012021120221202312024120262
Recent (last 2 years)Earlier